These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 25913014)

  • 21. Pharmacological and pharmacodynamic essentials of H(2)-receptor antagonists and proton pump inhibitors for the practising physician.
    Huang JQ; Hunt RH
    Best Pract Res Clin Gastroenterol; 2001 Jun; 15(3):355-70. PubMed ID: 11403532
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Recent topics in the medical treatment of reflux esophagitis].
    Hiraishi H; Shimada T; Terano A
    Nihon Geka Gakkai Zasshi; 1997 Nov; 98(11):942-6. PubMed ID: 9488979
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacologic strategies for treating gastroesophageal reflux disease.
    Vivian EM; Thompson MA
    Clin Ther; 2000 Jun; 22(6):654-72. PubMed ID: 10929915
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Medical treatments of GERD: the old and new.
    Vela MF
    Gastroenterol Clin North Am; 2014 Mar; 43(1):121-33. PubMed ID: 24503363
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Comparison between histamine H2-blocker and proton pump inhibitor on the effects of initial treatment in reflux esophagitis].
    Harasawa S
    Nihon Rinsho; 2000 Sep; 58(9):1847-52. PubMed ID: 11004814
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lymphocytic esophagitis: Still an enigma a decade later.
    Rouphael C; Gordon IO; Thota PN
    World J Gastroenterol; 2017 Feb; 23(6):949-956. PubMed ID: 28246468
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Symptom relief in gastroesophageal reflux disease: a randomized, controlled comparison of pantoprazole and nizatidine in a mixed patient population with erosive esophagitis or endoscopy-negative reflux disease.
    Armstrong D; Paré P; Pericak D; Pyzyk M;
    Am J Gastroenterol; 2001 Oct; 96(10):2849-57. PubMed ID: 11695354
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Histamine receptor antagonists, proton pump inhibitors and their combination in the treatment of gastro-oesophageal reflux disease.
    Katz PO; Tutuian R
    Best Pract Res Clin Gastroenterol; 2001 Jun; 15(3):371-84. PubMed ID: 11403533
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nocturnal acid breakthrough in children with reflux esophagitis taking proton pump inhibitors.
    Pfefferkorn MD; Croffie JM; Gupta SK; Molleston JP; Eckert GJ; Corkins MR; Fitzgerald JF
    J Pediatr Gastroenterol Nutr; 2006 Feb; 42(2):160-5. PubMed ID: 16456408
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Therapeutic approaches to healing esophagitis.
    Boyce HW
    Am J Gastroenterol; 1997 Apr; 92(4 Suppl):22S-27S; discussion 27S-29S. PubMed ID: 9127623
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Gastroesophageal reflux disease in pregnancy].
    Nikolov A; Pevtichev S; Petrova D
    Akush Ginekol (Sofiia); 2013; 52(7):35-40. PubMed ID: 24505639
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Managing reflux in infants: lifestyle modifications or medications?
    Heiberger A
    S D Med; 2014 Jun; 67(6):237-8. PubMed ID: 24979984
    [No Abstract]   [Full Text] [Related]  

  • 33. Management strategies for gastroesophageal reflux disease.
    Bak YT
    J Gastroenterol Hepatol; 2004 Sep; 19 Suppl 3():S49-53. PubMed ID: 15324382
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Proton pump inhibitors in acute healing and maintenance of erosive or worse esophagitis: a systematic overview.
    Chiba N
    Can J Gastroenterol; 1997 Sep; 11 Suppl B():66B-73B. PubMed ID: 9347181
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Medical therapy of extraesophageal gastroesophageal reflux disease.
    Katz PO
    J Clin Gastroenterol; 2000 Apr; 30(3 Suppl):S42-4. PubMed ID: 10777172
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Esomeprazole for the Treatment of Erosive Esophagitis in Children: An International, Multicenter, Randomized, Parallel-Group, Double-Blind (for Dose) Study.
    Tolia V; Youssef NN; Gilger MA; Traxler B; Illueca M
    J Pediatr Gastroenterol Nutr; 2015 Jul; 60 Suppl 1():S24-30. PubMed ID: 26121347
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Medical treatments in the short-term management of reflux esophagitis.
    Guirguis-Blake J
    Am Fam Physician; 2008 Mar; 77(5):620. PubMed ID: 18350759
    [No Abstract]   [Full Text] [Related]  

  • 38. Optimizing the Use of Medications and Other Therapies in Infant Gastroesophageal Reflux.
    Ciciora SL; Woodley FW
    Paediatr Drugs; 2018 Dec; 20(6):523-537. PubMed ID: 30198060
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of antacids, alginates and proton pump inhibitors: a survey of the general Danish population using an internet panel.
    Lødrup A; Reimer C; Bytzer P
    Scand J Gastroenterol; 2014 Sep; 49(9):1044-50. PubMed ID: 24874283
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Eosinophilic esophagitis in GERD patients: a clinicopathological diagnosis using proton pump inhibitors.
    Molina-Infante J; Ferrando-Lamana L; Fernandez-Bermejo M; Porcel-Carreño S
    Am J Gastroenterol; 2009 Nov; 104(11):2856-7. PubMed ID: 19888246
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.